Mar 20 |
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
|
Mar 14 |
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
|
Mar 13 |
Zomedica says talks ongoing with NYSE American to regain listing compliance
|
Mar 13 |
Zomedica Provides NYSE American Listing Update
|
Mar 12 |
Sidoti Events, LLC's Virtual March Small-Cap Conference
|
Mar 12 |
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
|